These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 3023775
21. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Mulder AH, Burger DM, Wardeh G, Hogenboom F, Frankhuyzen AL. Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074 [Abstract] [Full Text] [Related]
22. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia. Pasternak GW. Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3691-4. PubMed ID: 6251477 [Abstract] [Full Text] [Related]
28. Mu, but not kappa, opioid agonists induce contractions of the canine small intestine ex vivo. Hirning LD, Porreca F, Burks TF. Eur J Pharmacol; 1985 Feb 12; 109(1):49-54. PubMed ID: 2986990 [Abstract] [Full Text] [Related]
29. Opioid control of the ruminant stomach motility: functional importance of mu, kappa and delta receptors. Ruckebusch Y, Bardon T, Pairet M. Life Sci; 1984 Oct 22; 35(17):1731-8. PubMed ID: 6090847 [Abstract] [Full Text] [Related]
30. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones. Knox RJ, Dickenson AH. Brain Res; 1987 Jul 07; 415(1):21-9. PubMed ID: 2887243 [Abstract] [Full Text] [Related]
32. Analgesic effects of ethylketocyclazocine and morphine in rat and toad. Carr KD, Aleman DO, Holland MJ, Simon EJ. Life Sci; 1984 Aug 27; 35(9):997-1003. PubMed ID: 6433131 [Abstract] [Full Text] [Related]
33. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat. Laurent S, Schmitt H. Eur J Pharmacol; 1983 Dec 09; 96(1-2):165-9. PubMed ID: 6319158 [Abstract] [Full Text] [Related]
34. Discriminative stimulus properties of nalorphine in the rhesus monkeys. Tang AH, Code RA. J Pharmacol Exp Ther; 1983 Dec 09; 227(3):563-9. PubMed ID: 6317838 [Abstract] [Full Text] [Related]
35. The kappa opioid receptor and food intake. Morley JE, Levine AS, Kneip J, Grace M, Zeugner H, Shearman GT. Eur J Pharmacol; 1985 May 28; 112(1):17-25. PubMed ID: 2990965 [Abstract] [Full Text] [Related]
36. Mu and kappa opioid agonists elevate brain stimulation threshold for escape by inhibiting aversion. Carr KD, Bonnet KA, Simon EJ. Brain Res; 1982 Aug 12; 245(2):389-93. PubMed ID: 6289969 [Abstract] [Full Text] [Related]
37. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. Ward SJ, Takemori AE. J Pharmacol Exp Ther; 1983 Mar 12; 224(3):525-30. PubMed ID: 6131119 [Abstract] [Full Text] [Related]
38. Cardiac slowing induced by peripheral kappa-opiate receptor stimulation in rats. Gautret B, Schmitt H. Eur J Pharmacol; 1984 Jun 15; 102(1):159-63. PubMed ID: 6148245 [Abstract] [Full Text] [Related]
39. Opioid receptor agonists in the rabbit colon: comparison of in vivo and in vitro studies. Pairet M, Ruckebusch Y. Life Sci; 1984 Oct 15; 35(16):1653-8. PubMed ID: 6148681 [Abstract] [Full Text] [Related]
40. Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis. Bertalmio AJ, Woods JH. J Pharmacol Exp Ther; 1987 Nov 15; 243(2):591-7. PubMed ID: 2824753 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]